WuXi PharmaTech has launched WuXi V-Lab, a mobile app
Singapore: China's research contract service provider, WuXi PharmaTech, has launched WuXi V-Lab, a mobile app available to the global research community in need of small-molecule compound synthesis.
WuXi V-Lab allows customers to request organic compound synthesis through a mobile device with ease, speed, and flexibility. The application provides online functions for inquiry, quotation, order confirmation, project tracking, delivery confirmation, and payment.
"WuXi is one of the world's largest employers of chemists and a recognized leader in premier chemistry services," said Dr Ge Li, chairman and CEO, WuXi PharmaTech. "We are committed to integrating best-in-class R&D capabilities with cutting-edge mobile technologies to enable innovation-on-the-go by anyone, at any time, anywhere."
